Senior Investigator Pediatric Oncology Branch, Deputy Director-Center for Cancer Research
NCI, NIH
Naomi Taylor is a Deputy Director of the Center for Cancer Research and Senior Investigator in the Pediatric Oncology Branch (NCI, NIH). She studied at Princeton and the Weizmann Institute before earning her MD/PhD at Yale University School of Medicine with Dr. George Miller. Following pediatrics training at Yale and the Children’s Hospital of Los Angeles as a Howard Hughes Fellow, Dr. Taylor launched her own lab at the Institut de Génétique Moléculaire in Montpellier, France. She currently holds an adjunct professorship at the Université de Montpellier.
Dr. Taylor leads a research group internationally recognized for its work on T cell-based gene and cell therapies, metabolic regulation of normal and malignant hematopoiesis, and thymus differentiation. Recently, the group has pioneered studies exploring how metabolite transporters and cellular fuel choices shape immune and hematopoietic function. These efforts have identified novel metabolic programs regulating physiological and pathological hematopoietic lineage commitment, including erythropoiesis. Their discoveries have also directly informed the development of more effective T-cell immunotherapy protocols—advancing the design and performance of chimeric antigen receptor (CAR) T-cell therapies.
Dr. Taylor views science as a powerful platform for global collaboration, having mentored students and scientists from over 30 countries across six continents. Her dedication to research and training has been recognized with numerous honors, including the French National Inserm Research Award (2010), the NCI Director’s Award (2020), the NCI Women in Science Mentoring and Leadership Award (2021), and election to the Henry Kunkel Society and the Association of American Physicians (2023).
Disclosure information not submitted.
Hinges and Fuzzy Logic: New Tools for Achieving CAR/TCR Immunotherapeutic Precision
Friday, June 27, 2025
3:20pm - 3:45pm East Coast USA Time
